Quillin Comments on Arthrex Oral Arguments
10 March 2021
Thomson Reuters Westlaw IP
Partner George E. Quillin was quoted in the Thomson Reuters Westlaw IP article, “Supreme Court’s appointments clause ruling will keep PTAB intact, lawyers predict” about oral arguments in the closely-watched U.S. Supreme Court patent case, United States / Smith & Nephew v. Arthrex.
Quillin told Thomson Reuters: “A decision with the least immediate impact would be one in which the Court agrees with the government and Smith & Nephew that Administrative Patent Judges (APJ) have been inferior officers all along. Hence, there would be no need to for a judicial fix to anything.”
People
Related News
26 September 2024
In the News
Gregory Marino on NIL Litigation – 'Schools want to know where the line is, and now everything is in flux'
Foley & Lardner LLP special counsel Gregory Marino shared insight on the growing complexities of collegiate sports in the ABA Journal article, "Money and litigation tangle with recent rules for college athletes' NIL deals."
24 September 2024
In the News
Thomas Ferrante Assesses Recent HHS OIG Report on Remote Patient Monitoring
Foley & Lardner LLP partner Thomas Ferrante commented on the recently released report on remote patient monitoring from the U.S. Department of Health and Human Services Office of Inspector General (OIG) in the Fierce Healthcare article, “HHS watchdog flags potential remote monitoring fraud. Stakeholders say concerns about misuse are overblown.”
20 September 2024
In the News
David Rosen Featured for Insight on Looming FDA Final Rule for Cosmetic Manufacturing
Foley & Lardner LLP partner David Rosen is featured by CosmeticsDesign for his insights on the U.S. Food and Drug Administration's final rule establishing Good Manufacturing Practices for the cosmetics industry in the article, "Preparing for MoCRA’s 2025 cGMP deadline: What cosmetic manufacturers and suppliers need to know."